Clinical trial finds that oral drug MK-0616 substantially reduces ‘bad’ cholesterol
MK-016 could offer another potential option to achieve guideline-recommended LDL-C levels resulting in reduction of cardiovascular risk.
Read MoreMK-016 could offer another potential option to achieve guideline-recommended LDL-C levels resulting in reduction of cardiovascular risk.
Read MoreThe findings provide insight into the viral infection process, highlighting unique pathways and targets for developing effective therapeutics.
Read MoreFrom the Labs celebrates Heart Month with an image of a transparent mouse heart.
Read MoreInterim director Dr. Xiang “Shawn” Zhang sat down with From the Labs to provide an update on this multidisciplinary center dedicated to breast cancer research and patient care.
Read MoreHave you been keeping up with science discoveries at Baylor College of Medicine? Test your knowledge by answering these 20 questions.
Read MoreDid your favorite Momentum post one of the most popular posts in 2022? See our list of the top five most-viewed posts.
Read MoreCOVID-19 stay-at-home policies restricted the movement of individuals, especially adolescents and young adults. At the onset of the pandemic, we at the Baylor Teen Health
Read More“Ay, thou poor Ghost, while memory holds a seat In this distracted globe. Remember thee! Yea, from the table of my memory I’ll wipe away
Read MoreBaylor researchers conduct studies to investigate more effective treatments and detection methods for pancreatic cancer
Read MoreDr. Laura Detti answers questions about fertility treatments, the latest advancements and when should women check their fertility.
Read More